Healthcare -
Biotechnology - NASDAQ - CH
$ 33.83
-11.9 %
$ 2.92 B
Market Cap
-7.64
P/E
CRSP - REVENUE
Revenue CRSP - CRISPR Therapeutics AG
35 M
LAST VALUE
795.96%
2 YEAR CAGR
-34.47%
5 YEAR CAGR
0.00%
10 YEAR CAGR